GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alteogen Inc (XKRX:196170) » Definitions » Sale Of Investment

Alteogen (XKRX:196170) Sale Of Investment : ₩152,879 Mil (TTM As of Dec. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Alteogen Sale Of Investment?

Alteogen's sale of investment for the three months ended in Dec. 2024 was ₩81,126 Mil. It means Alteogen gained ₩81,126 Mil from selling investments. Alteogen's sale of investment for the trailing twelve months (TTM) ended in Dec. 2024 was ₩152,879 Mil.

Compared with last quarter (₩10,000 Mil in Sep. 2024 ), Alteogen gained more money from selling investments in Dec. 2024 (₩81,126 Mil).


Alteogen Sale Of Investment Historical Data

The historical data trend for Alteogen's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alteogen Sale Of Investment Chart

Alteogen Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Sale Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only 361.98 185,652.00 402,587.00 187,683.73 152,878.99

Alteogen Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 58,513.94 13,969.21 47,784.09 No Debt 81,125.69

Alteogen Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩152,879 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Alteogen Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Alteogen's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


Alteogen Business Description

Traded in Other Exchanges
N/A
Address
62, Yuseong-daero 1628beon-gil, Yuseong-gu, Daejeon, KOR, 34054
Alteogen Inc Inc is engaged in the development and manufacture of next-generation biopharmaceuticals using NexP Fusion Technology. It also develops & markets biobetters and biosimilars by partnerships with pharmaceutical companies. It focuses on the areas such as biobetters, a proprietary antibody-drug conjugate, and antibody biosimilars with complexity.

Alteogen Headlines

No Headlines